Beporinon 10 mg (Bepotastine Besilate)

Adult dose

In adults, bepotastine besilate is usually administered orally at a dose of 10mg twice daily. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be administered to patients with hypersensitivity to its components. Caution should be exercised when administering this medication to patients with impaired kidney or liver function and to the elderly. In clinical trials, various side effects such as drowsiness, headache, dizziness, vomiting, diarrhea, and skin rashes have been reported in some patients taking this medication. Drowsiness may occur while taking this medication, so it is advisable to avoid driving or operating hazardous machinery. Patients who have received long-term steroid treatment should make dosage adjustments gradually when taking this medication. For patients with impaired kidney function, the plasma concentration of this medication may increase; therefore, it is recommended to start with a low dose and reduce the dosage or temporarily discontinue it if adverse symptoms arise. The use of this medication in patients with seasonal allergic rhinitis has not been sufficiently studied, thus caution should be used, it is preferable to start taking it before the onset of symptoms and continue during the symptomatic period. It is advisable not to take this medication for extended periods if no effects are confirmed. Avoid taking this medication with other antihistamines or excessive alcohol. Pregnant women or women who may become pregnant are advised not to take this medication; if unavoidable, consultation with a doctor before taking it is recommended. Breastfeeding women are also advised to avoid taking this medication while nursing. The safety of this medication in children has not been established, therefore caution is necessary when administering it to children. Elderly patients should exercise caution due to the risk of increased concentration of this medication caused by diminished kidney function. This medication may interfere with allergen skin reaction tests; thus, it is advisable not to take it prior to testing. When taking this medication, it should be removed from its packaging before ingestion, as swallowing it with the packaging could cause esophageal damage. Store in a tightly closed container to prevent exposure to air or moisture, and it is best to store it at room temperature between 1°C and 30°C. This way, the effectiveness of the medication can be maintained for a longer period.

• Drowsiness
• lethargy
• headache
• heaviness
• dizziness
• thirst
• dry mouth
• inflammation of the tongue
• nausea
• vomiting

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best to store it at room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance

White, round, film-coated tablet with a score line

Package unit

30 tablets/bottle, 300 tablets/bottle